Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroses, Pulmonary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02404714
What this trial is testing

A Multi-Center Study of the CF Quantum® Sweat Test System

Who this might be right for
Cystic Fibrosis
Polychrome Medical, Inc. 55
Not applicableUnknownNCT04619199
What this trial is testing

Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary DiseasePulmonary Medicine
Assistance Publique - Hôpitaux de Paris 200
Not applicableStudy completedNCT04579939
What this trial is testing

Oral Glucose Tolerance Testing Using Candy for Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Mayo Clinic 10
Not applicableStudy completedNCT03381157
What this trial is testing

Fidgety Movements in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Hacettepe University 38
Large-scale testing (Phase 3)Study completedNCT03843541
What this trial is testing

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Who this might be right for
Respiratory Tract DiseasesAbnormal Mucus Secretions
Zambon SpA 333
Not applicableUnknownNCT05174741
What this trial is testing

Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.

Who this might be right for
PneumoniaPulmonary FibrosisTuberculosis+2 more
Riphah International University 20
Not applicableStudy completedNCT04131972
What this trial is testing

REGENERA Implant in Excised Non-Malignant Breast Lesions

Who this might be right for
Benign Breast Disease
Tensive SRL 15
Not applicableUnknownNCT02535130
What this trial is testing

Evaluation of Nebulization and Positive Expiratory Pressure Combination

Who this might be right for
Cystic FibrosisHealthy Subjects
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 15
Testing effectiveness (Phase 2)Study completedNCT03489629
What this trial is testing

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

Who this might be right for
Cystic Fibrosis
University of North Carolina, Chapel Hill 49
Not applicableUnknownNCT04990531
What this trial is testing

Low-field Magnetic Resonance Imaging of Pediatric COVID-19

Who this might be right for
Sars-CoV-2 InfectionLung FibrosisCovid19
University of Erlangen-Nürnberg Medical School 68
Not applicableLooking for participantsNCT06615492
What this trial is testing

Routine vs On-demand ECMO for Lung Transplantation

Who this might be right for
Respiratory FailureInterstitial Lung Disease (ILD)Pulmonary Fibrosis+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 218
Testing effectiveness (Phase 2)Looking for participantsNCT05139719
What this trial is testing

Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd. 110
Testing effectiveness (Phase 2)Study completedNCT02048644
What this trial is testing

Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hull University Teaching Hospitals NHS Trust 20
Not applicableWithdrawnNCT00231192
What this trial is testing

Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes

Who this might be right for
Diabetes
Children's Hospital of Philadelphia
Post-approval studies (Phase 4)Study completedNCT02598193
What this trial is testing

Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 89
Testing effectiveness (Phase 2)Study completedNCT04512547
What this trial is testing

Oxidative Stress in Asthma

Who this might be right for
AsthmaObesity
Bastiaan Driehuys 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT05389215
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co. LTD. 102
Testing effectiveness (Phase 2)Study completedNCT01051999
What this trial is testing

Glutamine Supplementation in Cystic Fibrosis

Who this might be right for
Cystic FibrosisImmune Function
Emory University 17
Not applicableEnrolling By InvitationNCT06885515
What this trial is testing

Telomeres Length in Israeli Fibrotic ILD Patients

Who this might be right for
Pulmonary Fibrosis
Barzilai Medical Center 100
Testing effectiveness (Phase 2)UnknownNCT03669614
What this trial is testing

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

Who this might be right for
Cystic Fibrosis
Aridis Pharmaceuticals, Inc. 102
Next Page